ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meeting Abstracts
    • All Meetings
    • PRSYM 2026
    • ACR Convergence 2025
    • Download Abstract Supplements
  • Keyword Index
  • Search
  • My Favorites
    • View and print all favorites
    • Clear all favorites

Abstract Number: 1710

Defining sonographic enthesitis in psoriatic arthritis: Developing a data- and expert-driven definition for inflammatory enthesitis at the single enthesis level

Andre Lucas Ribeiro1, Sibel Aydin2, Gurjit Kaeley3, Fahmeen J. Afgani4, Catherine Bakewell5, Marcos Rosemffet6, Minna Kohler7, Amir Haddad8, Maria S. Stoenoiu9, Ari Polachek10, josefina marin11, Arnon Katz12, Sahil Koppikar13 and Lihi Eder14, 1Hospital de Clínicas de Porto Alegre, Porto Alegre, Rio Grande do Sul, Brazil, 2Department of Medicine, University of Ottawa, The Ottawa Hospital Research Institute, Ottawa, ON, Canada, 3UF COM-J, Ponte Vedra Beach, FL, 4Women's College Hospital, Toronto, Canada, 5Intermountain Healthcare, Salt Lake City, UT, 6Instituto de Rehabilitación Psicofísica, Capital Federal, Argentina, 7Massachusetts General Hospital, Harvard Medical School, Boston, MA, 8Carmel Medical Centre, Haifa, Israel, 9Cliniques Universitaires Saint-Luc, Brussels, Belgium, 10Rheumatology Institute of Beilinson Hospital, Petah Tikva, Israel, 11Hospital Universitario Rey Juan Carlos, Madrid, Spain, 12GRAPPA, Seattle, 13Women's College Hospital & University of Toronto, Markham, ON, Canada, 14University of Toronto, Toronto, ON, Canada

Meeting: ACR Convergence 2025

Keywords: Cohort Study, Diagnostic criteria, Imaging, Psoriatic arthritis, Ultrasound

  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print
Session Information

Date: Monday, October 27, 2025

Title: Abstracts: Spondyloarthritis Including Psoriatic Arthritis – Diagnosis, Manifestations, & Outcomes I: Advances in Psoriatic Disease (1710–1715)

Session Type: Abstract Session

Session Time: 3:00PM-3:15PM

Background/Purpose: Enthesitis affects 30–40% of PsA patients but remains difficult to diagnose due to overlap with non-specific entheseal pain. While OMERACT has standardized ultrasound (US) elementary lesions, no validated definition of inflammatory enthesitis (IE) exists at the single-enthesis level. This limits diagnostic specificity and contributes to misclassification and overtreatment. We aimed to develop an expert- and data-driven definition of sonographic IE at the single-enthesis level in PsA, with the goal of improving diagnostic accuracy and patient selection for clinical research.

Methods: Ten expert sonographers from the DUET (Diagnostic Ultrasound Enthesitis Tool)1 study independently reviewed 90 US video scans of PsA patients at six entheseal sites. Each scan was score from –10 (“Definite not IE”) to +10 (“Definite IE”), and those with ≥70% agreement and scores of +7 were labeled “Definite IE.” Experts annotated key sonographic features influencing their assessments. Quantitative analysis included group comparison of elementary lesion distribution using the DUET consensus scoring for descriptive statistics and chi-square tests. Thematic analysis was performed on free-text annotations. This data was used to inform a proposed definition of IE, which was subsequently approved through a Delphi vote.

Results: Of 90 scans, 29 (32.2%) were “Definite IE”, 21 (23.3%) “Definite not IE”, and 40 (44.5%) “Uncertain”. Most “Definite IE” had ≥4 elementary lesions, while “Uncertain” scans commonly had 2 to 4 lesions (Figure 1A). The absence of elementary lesions or presence of isolated findings characterized the “Definite not IE” group.Power Doppler (PD) grade ≥ 2 near the bone cortex was present in 97% of the “Definite IE” group and in 55% of “Uncertain” scans (Figure 1B, Figure 2F). Importantly, grades 2-3 PD were almost exclusively found in these two groups, with grade 3 almost only found in the “Definite IE” group. Thematic analysis revealed that lesion combinations, cortical location of PD, and contextual interpretation were critical for classification. Isolated findings (e.g., small enthesophytes) lacked diagnostic value unless part of a broader inflammatory pattern. Structural lesions (e.g., cortical irregularities, erosions) were interpreted as signs of prior inflammatory process.Based on these findings the proposed definition for IE is ““The presence of a power Doppler signal grade ≥2 near the bone cortex, in the presence of hypoechogenicity and/or thickening of the entheseal structure, and within the appropriate clinical context*.” This excludes cases where findings are better explained by mechanical stress or trauma.” (Table 1). This definition achieved consensus in the Delphi exercise (10 out of 10 voted to approve).

Conclusion: The new proposed definition for sonographic IE in the context of PsA should facilitate the development of standardized diagnostic criteria for IE in PsA, and improve patient enrollment specificity in clinical research.Reference: Eder L, Aydin S, Kaeley G, et al. Arthritis Rheumatol. 2020;72(Suppl 10). Abstract.

Supporting image 1Table 1. New definition of inflammatory enthesitis at the single-enthesis level.

Supporting image 2Figure 1A . Number of elementary lesions identified in each category; 1B. Distribution of sonographic elementary lesions by category.

Supporting image 3Figure 2. The prevalence of elementary lesions by enthesitis definition category. 1A. Hypoechogenicity (score 0-1); 1B. Enthesophyte (score 0-3); 1C.

Thickening (score 0-1); 1D Calcification (Score 0-3); 1E. Erosion (score 0-1); 1F. Power Doppler (score 0-3). Chi-square test was performed to compare

the “definite enthesitis” and “uncertain” groups, with p-value < 0.05 marked with an asterisk (*) and a p-value < 0.01 marked with two asterisks.


Disclosures: A. Lucas Ribeiro: AbbVie/Abbott, 2, 6, Eli Lilly, 6, Janssen, 2, 6, Novartis, 6, UCB, 5, 6; S. Aydin: AbbVie/Abbott, 5, 6, Eli Lilly, 5, 6, Janssen, 5, 6, Novartis, 5, 6, Pfizer, 5, 6, UCB, 5, 6; G. Kaeley: AbbVie/Abbott, 5, Bristol-Myers Squibb(BMS), 5, Gilead, 5, Janssen, 5, Novartis, 5; F. Afgani: None; C. Bakewell: AbbVie/Abbott, 2, 6, Eli Lilly, 2, 6, Janssen, 2, 6, Novartis, 2, Pfizer, 2, 6, UCB, 2, 6; M. Rosemffet: None; M. Kohler: Janssen, 5, 12, medical advisory board, Novartis, 12, medical advisory board, Setpoint Medical, 5, Springer Publications, 9; A. Haddad: AbbVie/Abbott, 6, AstraZeneca, 6, Janssen, 6, Novartis, 6; M. Stoenoiu: AbbVie/Abbott, 5, 6, Janssen, 5, 6, Novartis, 5, 6, Pfizer, 5, 6, Roche, 5, 6, Sanofi, 5, 6, UCB, 5, 6; A. Polachek: None; j. marin: None; A. Katz: None; S. Koppikar: AbbVie/Abbott, 1, 2, 5, 6, Novartis, 2, 6, Pfizer, 12, Unrestricted educational grant for Northern Ontario Clinic, UCB, 2, 6; L. Eder: AbbVie, 1, 2, 5, 6, BMS, 1, 2, Eli Lilly, 1, 2, 5, 6, Fresenius Kabi, 1, 5, J&J, 1, 2, 5, Janssen, 1, 5, Novartis, 1, 2, 5, 6, Pfizer, 1, 2, 5, UCB, 1, 2, 5.

To cite this abstract in AMA style:

Lucas Ribeiro A, Aydin S, Kaeley G, Afgani F, Bakewell C, Rosemffet M, Kohler M, Haddad A, Stoenoiu M, Polachek A, marin j, Katz A, Koppikar S, Eder L. Defining sonographic enthesitis in psoriatic arthritis: Developing a data- and expert-driven definition for inflammatory enthesitis at the single enthesis level [abstract]. Arthritis Rheumatol. 2025; 77 (suppl 9). https://acrabstracts.org/abstract/defining-sonographic-enthesitis-in-psoriatic-arthritis-developing-a-data-and-expert-driven-definition-for-inflammatory-enthesitis-at-the-single-enthesis-level/. Accessed .
  • Tweet
  • Email a link to a friend (Opens in new window) Email
  • Print (Opens in new window) Print

« Back to ACR Convergence 2025

ACR Meeting Abstracts - https://acrabstracts.org/abstract/defining-sonographic-enthesitis-in-psoriatic-arthritis-developing-a-data-and-expert-driven-definition-for-inflammatory-enthesitis-at-the-single-enthesis-level/

Advanced Search

My Favorites

Save and print abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract (must have cookies enabled in browser). See saved favorites.

Abstract Policies

  • ACR Convergence Abstract Embargo Policies
  • ACR Convergence Abstract Permissions & Reprints
  • PRSYM Abstract Policies

ACR Convergence. Where Rheumatology Meets

ACR Convergence 2026

Join us November 6-11 in Orlando, Florida.
See Registration Information

  • Contact ACR
  • Privacy Policy
  • ACR Policies
  • Cookie Preferences

© Copyright 2026 American College of Rheumatology